Prevalence of HTLV-I-associated T-cell lymphoma

Area of Science:

• Virology
• Oncology
• Epidemiology

Background:

• Human retroviral infections, including HTLV and HIV, pose significant public health concerns.
• HTLV-I is linked to T-cell lymphomas and other diseases, necessitating prevalence assessment.
• Understanding retroviral prevalence is crucial for targeted prevention and treatment strategies.

Purpose of the Study:

• To determine the prevalence of HTLV-I-associated T-cell lymphomas and general human retrovirus infections.
• To identify populations with increased risk for HTLV and HIV infections.
• To evaluate the association between HTLV-I and specific lymphoma subtypes.

Main Methods:

• Serologic and PCR assays were used to test approximately 21,000 individuals for HTLV-I, HTLV-II, HIV-1, and HIV-2.
• Study populations included blood donors, various patient groups, and individuals at retroviral risk.
• Prevalence rates were analyzed across different demographic and clinical subgroups.

Main Results:

• Low HTLV (0.02%) and HIV (0%) prevalence was found in volunteer blood donors.
• Elevated HTLV prevalence was observed in paid donors, African Americans, Amerindians, and specific patient groups.
• HTLV-I was detected in 4% of other-than-low-grade NHL patients, with aggressive T-cell lymphomas and poor prognosis.

Conclusions:

• HTLV-I-associated lymphoma, though uncommon, is a significant concern among certain NHL cases in the US.
• Increased HTLV and HIV-1 prevalence was noted in specific high-risk populations.
• HTLV-I lymphoma warrants separate clinical investigation due to its poor prognosis.